Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer

Mehmet Eser,Metin Kement,Salim Balin,Cihan Coşkun,Umut Kefeli,Mahmut Gumus,Yunus Emre Altuntas,Necmi Kurt,Alparslan Mayadagli

Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer

2012

Mehmet Eser
Metin Kement
Salim Balin
Cihan Coşkun
Umut Kefeli
Mahmut Gumus
Yunus Emre Altuntas
Necmi Kurt
Alparslan Mayadagli

Background The purpose of this study was to investigate plasma levels of thrombin activatable fibrinolysis inhibitor (TAFI) and TAFI’s relationship with coagulation markers (prothrombin fragment 1 + 2) in gastric cancer patients.

Keywords:

Cancer
Gastroenterology
Prospective cohort study
Pathology
Prothrombin fragment 1
Thrombin-Activatable Fibrinolysis Inhibitor
Surgical oncology
Thrombophilia
Carboxypeptidase U
Medicine
Diabetes mellitus
Endocrinology
Internal medicine
Disease
Thrombosis
Pathogenesis
Body mass index

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations